Literature DB >> 24909440

[Resistance to fluoroquinolones in 2013: what are the consequences in internal medicine?].

V de Lastours1, B Fantin2.   

Abstract

Because of their important qualities, fluoroquinolones are amongst the most prescribed antibiotics in the world. The corollary of this success is the rapid increase in resistance to fluoroquinolones, responsible for treatment failures. Moreover, fluoroquinolone-resistance is often accompanied by resistance to other classes of antibiotics. Currently, significant levels of resistance are found both in hospitals and in community settings, severely limiting possibilities for empirical use of fluoroquinolones. A major mechanism explaining the rapid emergence of resistance to fluoroquinolones is their specific impact on human microbiota and the selection of resistant strains in the microbiota, which seems to be an unavoidable ecological side effect. In order to preserve the efficiency of this important class of antibiotics, limiting their use and respecting good practice recommendations are essential.
Copyright © 2014 Société nationale française de médecine interne (SNFMI). Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Antibiotic resistance; Fluoroquinolones; Recommandations; Recommendations; Résistance aux antibiotiques

Mesh:

Substances:

Year:  2014        PMID: 24909440     DOI: 10.1016/j.revmed.2014.05.005

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  3 in total

1.  Clinical Benefit of Appropriate Empirical Fluoroquinolone Therapy for Adults with Community-Onset Bacteremia in Comparison with Third-Generation-Cephalosporin Therapy.

Authors:  Ching-Chi Lee; Jiun-Ling Wang; Chung-Hsun Lee; Chih-Chia Hsieh; Yuan-Pin Hung; Ming-Yuan Hong; Hung-Jen Tang; Wen-Chien Ko
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

2.  Prescription of Levofloxacin and Moxifloxacin in Select Hospitals in Uganda: A Pilot Study to Assess Guideline Concordance.

Authors:  Victoria Nambasa; Helen B Ndagije; Allan Serwanga; Leonard Manirakiza; Joanitah Atuhaire; Diana Nakitto; Ronald Kiguba; Albert Figueras
Journal:  Antibiotics (Basel)       Date:  2020-07-23

3.  In Vitro Screening of a 1280 FDA-Approved Drugs Library against Multidrug-Resistant and Extensively Drug-Resistant Bacteria.

Authors:  Lucie Peyclit; Sophie Alexandra Baron; Linda Hadjadj; Jean-Marc Rolain
Journal:  Antibiotics (Basel)       Date:  2022-02-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.